EP3493809
ENASIDENIB FOR TREATMENT OF MYELODYSPLASTIC SYNDROME
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.8.2017EP published:
23.8.2023EP application number:
17752530.0
EPO information:
European Patent Register
Max expiry date:
1.8.2037
Title in English:
ENASIDENIB FOR TREATMENT OF MYELODYSPLASTIC SYNDROMELanguage of the patent:
English
Timeline
Today
2.8.2017EP application
23.8.2023EP Publication
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Inventor
Name:
AMATANGELO, MichaelAddress:
Madison NJ 07940, US
Name:
HU, XiaolanAddress:
Skillman NJ 08558, US
Name:
THAKURTA, AnjanAddress:
Basking Ridge NJ 07920, US
Priority
Number:
201662370673 PDate:
3.8.2016Country:
US
Number:
201662429649 PDate:
2.12.2016Country:
US
Classification
Categories:
A61K 31/53, A61K 9/00, A61K 9/02, A61K 9/06, A61K 9/12, A61K 9/28, A61K 9/48, A61K 9/70, A61K 9/20, A61P 35/00